Skip to main content
. 2019 Dec 11;28(1):44–50. doi: 10.4103/ipj.ipj_57_19

Table 4.

Score of baclofen and topiramate group in obsessive and compulsive drinking scale during each assessment

Variables Group Baseline 1st week 2nd week 3rd week 4th week
Dose (mg) (mention values as mean±SD) Baclofen - 20±0.0 23.04±6.641 23.91±6.593 23.81±6.890
Topiramate - 25±0.0 50±0.0 120±25.162 125±35.355
OCD (O) Baclofen 13.24±2.654 9.96±3.994@ 6.64±4.156 3.52±4.155 1.19±3.501©
Topiramate 14.0±3.628 13.04±3.702* 10.08±4.319*,∞ 8.27±4.783*,€ 4.05±4.892*
OCD (C) Baclofen 13.28±2.913 7.76±5.789@ 2.56±5.007 1.95±4.324 0.81±3.709©
Topiramate 14.36±3.321 13.04±3.948* 9.36±5.724**,∞ 6.52±6.816**,€ 2.77±5.275*
OCD (T) Baclofen 26.52±5.581 16.64±10.123@ 9.21±7.942 5.48±7.983 2.0±7.036©
Topiramate 28.36±6.769 26.08±7.410* 19.44±9.747**,∞ 14.5±11.359**,€ 6.83±9.855*
VAS Baclofen 81.2±8.817 63.2±17.072@ 39.56±14.924 24.78±23.906 6.19±18.568©
Topiramate 82.4±10.116 78±11.547* 65.2±17.823*,∞ 48.63±26.603*,€ 25.56±28.122*
Average drinking days/past week Baclofen 6.72±0.791 2.36±2.721@ 0.782±1.730 0.434±1.502 0.428±1.535©
Topiramate 6.44±1.044 5.12±1.833* 3.32±2.495 2.22±2.810 1.00±2.143©
Average number of drinks Baclofen 10.16±0.862 4.10±2.030@ 2.356±1.466 1.356±1.160 0.871±1.434©
Topiramate 11.92±0.959 6.40±0.931* 4.96±1.262 3.045±1.565 1.471±1.395©

*Significant difference between baclofen and topiramate (0.05), **Significant difference between baclofen and topiramate (0.001), @Significant difference between baseline and 1st week assessment, Significant difference between baseline and 2nd week assessment, Significant difference between baseline and 3rd week assessment, ©Significant difference between baseline and 4th week assessment. OCD – Obsessive and compulsive drinking; SD – Standard deviation; VAS – Visual Analog Scale